EBITDA: Income before interest, taxes, depreciation and amortization.
Revolution Medicines, Inc. (RVMD) had EBITDA of $-500.08M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$11.58M |
|
$-436.37M |
|
-- |
|
$11.58M |
|
$498.76M |
|
$-487.19M |
|
$47.29M |
|
$-439.89M |
|
$-439.89M |
|
$-436.37M |
|
$-436.37M |
|
$-436.37M |
|
$-436.37M |
|
$-487.19M |
|
|
EBITDA |
$-500.08M |
113.15M |
|
113.15M |
|
$-3.86 |
|
$-3.86 |
|
| Balance Sheet Financials | |
$1.88B |
|
$22.86M |
|
$182.42M |
|
$2.06B |
|
$143.85M |
|
-- |
|
$91.66M |
|
$235.51M |
|
$1.83B |
|
$1.75B |
|
$1.83B |
|
164.68M |
|
| Cash Flow Statement Financials | |
$-350.57M |
|
$-342.60M |
|
$1.23B |
|
$163.15M |
|
$699.18M |
|
$536.03M |
|
$61.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4207.12% |
|
-4207.12% |
|
-4318.49% |
|
-3798.71% |
|
-3768.28% |
|
$-358.30M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
9.23 |
|
39.53 |
|
-23.89% |
|
-24.88% |
|
-21.17% |
|
-23.89% |
|
$11.09 |
|
$-3.17 |
|
$-3.10 |
|